(1)Inter Med 49: 267-271, 2010
Elevation of Serum Immunoglobulin G in Hashimoto’s
Thyroiditis and Decrease after Treatment with
L-Thyroxine in Hypothyroid Patients
Department of Diabetes & Endocrinology, Nagano Red Cross Hospital, Nagano,
Department of Internal Medicine, Kashiwa Municipal Hospital,
Kashiwa,
Department of Internal Medicine, Fujimura Hospital, Ageo and Center for Medical Education, Shinshu University School of Medicine, Matsumoto
Download:
http://www.jstage.jst.go.jp/article/int ... 4/267/_pdf
(2)CLINICALTHYROIDOLOGY
FEBRUARY 2010
AUTOIMMUNE THYROID DISEASE
Patients with a primary diagnosis of autoimmune thyroid disease are
at significantly increased risk for additional autoimmune diseases
CONCLUSION
Patients with a primary diagnosis of autoimmune thyroid disease are at significantly increased risk for additional autoimmune diseases. The authors of the study suggest that these risks highlight the importance of screening for other autoimmune diagnoses if patients with autoimmune thyroid disease present with new or nonspecific symptoms.
Zie ook:
COMMENTARY
This is perhaps the largest study to quantify the risk for coexisting autoimmune diseases in more than 3000 index cases with well-characterized Graves’ disease or Hashimoto’s thyroiditis.
met de rest:
Artikel (4 pagina's):
http://www.thyroid.org/professionals/pu ... _16_19.pdf
(3)February 2010
Family Medicine
Antithyroid Peroxidase Antibodies in Patients With High Normal Range Thyroid Stimulating Hormone
From the Department of Family and Community Medicine (Drs Zelaya, Stotts, and Moreno) and Department of Internal Medicine (Dr Nader), University of Texas-Houston Medical School.
Download:
http://www.stfm.org/fmhub/fm2010/February/Ana111.pdf
(4)Proc (Bayl Univ Med Cent). 2010 January
Blanched fingers
From the Division of Dermatology, Department of Internal Medicine, Baylor University Medical Center, Dallas, Texas.
Volledig artikel te lezen:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2804497/
(5)Published online 2010 January 11
Effect of Leucovorin (Folinic Acid) on the Developmental Quotient of Children with Down's Syndrome (Trisomy 21) and Influence of Thyroid
1Institut Jerome Lejeune, Paris, France
2Laboratory of Applied Mathematics, Agrocampus, Rennes, France
3National Academy of Medicine, Paris, France
4Department of Biochemistry and Molecular Genetics, University of Limoges, Limoges, France
Joel Gagnier, EditorUniversity of Toronto, Canada
Volledig artikel te lezen:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2799517/
(6)Gastroenterol Res Pract. 2009
Does Hypothyroidism Affect Gastrointestinal Motility?
Background.
Gastrointestinal motility and serum thyroid hormone levels are closely related.
Our aim was to analyze whether there is a disorder in esophagogastric motor functions as a result of hypothyroidism.
Materials and Methods.
The study group included 30 females (mean age ± SE 45.17 ± 2.07 years) with primary hypothyroidism and 10 healthy females (mean age ± SE 39.40 ± 3.95 years).
All cases underwent esophagogastric endoscopy and scintigraphy.
For esophageal scintigraphy, dynamic imaging of esophagus motility protocol, and for gastric emptying scintigraphy, anterior static gastric images were acquired.
Results.
The mean esophageal transit time (52.56 ± 4.07sec for patients; 24.30 ± 5.88sec for controls; P = .02) and gastric emptying time (49.06 ± 4.29min for the hypothyroid group; 30.4 ± 4.74min for the control group; P = .01) were markedly increased in cases of hypothyroidism.
Conclusion.
Hypothyroidism prominently reduces esophageal and gastric motor activity and can cause gastrointestinal dysfunction
Link:
http://www.ncbi.nlm.nih.gov/pmc/article ... =pmcentrez
(7)Proc Natl Acad Sci U S A. 2010 March
Thyroid hormone exerts negative feedback on hypothalamic type 4 melanocortin receptor expression
The type 4 melanocortin receptor MC4R, a key relay in leptin signaling, links central energy control to peripheral reserve status.
MC4R activation in different brain areas reduces food intake and increases energy expenditure.
Mice lacking Mc4r are obese. Mc4r is expressed by hypothalamic paraventricular Thyrotropin-releasing hormone (TRH) neurons and increases energy usage through activation of Trh and production of the thyroid hormone tri-iodothyronine (T3).
These facts led us to test the hypothesis that energy homeostasis should require negative feedback by T3 on Mc4r expression.
Quantitative PCR and in situ hybridization showed hyperthyroidism reduces Mc4r mRNA levels in the paraventricular nucleus.
Comparative in silico analysis of Mc4r regulatory regions revealed two evolutionarily conserved potential negative thyroid hormone-response elements (nTREs).
In vivo ChIP assays on mouse hypothalamus demonstrated association of thyroid hormone receptors (TRs) with a region spanning one nTRE.
Further, in vivo gene reporter assays revealed dose-dependent T3 repression of transcription from the Mc4r promoter in mouse hypothalamus, in parallel with T3-dependent Trh repression.
Mutagenesis of the nTREs in the Mc4r promoter demonstrated direct regulation by T3, consolidating the ChIP results.
In vivo shRNA knockdown, TR over-expression approaches and use of mutant mice lacking specific TRs showed that both TRá and TRâ contribute to Mc4r regulation.
T3 repression of Mc4r transcription ensures that the energy-saving effects of T3 feedback on Trh are not overridden by MC4R activation of Trh.
Thus parallel repression by T3 on hypothalamic Mc4r and Trh contributes to energy homeostasis
Fig. 1.
Thyroid status alters Mc4r expression in the hypothalamic PVN. (A) Real-time PCR quantification of Mc4r and Trh mRNA from PVN of adult male mice treated for 13 days by PTU (hypothyroid) or T4 (hyperthyroid), or euthyroid controls (Ct) Gene expression (more ...)
Fig. 4.
Schema of T3 repression of Mc4r expression in brain. The physiological consequences of modified thyroid status on Trh and Mc4r gene regulation and metabolic output are played out through modulation of Mc4r expression in key brain areas affecting metabolism, (more ...)
Link:
http://www.ncbi.nlm.nih.gov/pmc/article ... =pmcentrez
(8)PLoS Genet. 2009 December
Autoimmune Disease Classification by Inverse Association with SNP Alleles
Stanford Center for Biomedical Informatics Research, Stanford University School of Medicine, Stanford, California, United States of America
2Department of Pediatrics, Stanford University School of Medicine, Stanford, California, United States of America
3Lucile Packard Children’s Hospital, Palo Alto, California, United States of America
4Computer Science Department, Stanford University, Stanford, California, United States of America
5Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, California, United States of America
6Geriatric Research Education and Clinical Center, Veterans Affairs Palo Alto Health Care System, Palo Alto, California, United States of America
David B. Allison, Editor
With multiple genome-wide association studies (GWAS) performed across autoimmune diseases, there is a great opportunity to study the homogeneity of genetic architectures across autoimmune disease.
Previous approaches have been limited in the scope of their analysis and have failed to properly incorporate the direction of allele-specific disease associations for SNPs.
In this work, we refine the notion of a genetic variation profile for a given disease to capture strength of association with multiple SNPs in an allele-specific fashion.
We apply this method to compare genetic variation profiles of six autoimmune diseases:
multiple sclerosis (MS), ankylosing spondylitis (AS), autoimmune thyroid disease (ATD), rheumatoid arthritis (RA), Crohn's disease (CD), and type 1 diabetes (T1D), as well as five non-autoimmune diseases.
We quantify pair-wise relationships between these diseases and find two broad clusters of autoimmune disease where SNPs that make an individual susceptible to one class of autoimmune disease also protect from diseases in the other autoimmune class.
We find that RA and AS form one such class, and MS and ATD another.
We identify specific SNPs and genes with opposite risk profiles for these two classes.
We furthermore explore individual SNPs that play an important role in defining similarities and differences between disease pairs.
We present a novel, systematic, cross-platform approach to identify allele-specific relationships between disease pairs based on genetic variation as well as the individual SNPs which drive the relationships.
While recognizing similarities between diseases might lead to identifying novel treatment options, detecting differences between diseases previously thought to be similar may point to key novel disease-specific genes and pathways.
Autoimmune diseases share many genetic factors resulting in similarity of disease mechanisms.
For instance the HLA region is known to be associated with several autoimmune diseases including T1D, MS, RA as well as others [1],[2].
Certain autoimmune diseases, such as MS and ATD [3], T1D and celiac disease [4] commonly co-occur in patients [5],[6].
Classes of drugs, for instance steroids, are known to treat groups of inflammatory and autoimmune conditions such as RA, CD, MS and systemic lupus erythematosus
Figure 1
Disease heatmap based on genetic variation profiles.
http://www.ncbi.nlm.nih.gov/pmc/article ... 0792-g001/
Figure 2
Genetic Variation Scores for RA (WTCCC) and ATD.
http://www.ncbi.nlm.nih.gov/pmc/article ... 0792-g002/
Figure 5
Genetic Variation Scores for ATD and T1D.
http://www.ncbi.nlm.nih.gov/pmc/article ... 0792-g005/
en meer:
Link:
http://www.ncbi.nlm.nih.gov/pmc/article ... =pmcentrez
